CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-14 | Kaye Edward M. MD Director | Option exercise · Performance Stock Units | −26,250 | 26,250 | ||
| 2025-08-13 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −13,712 | $15.00 | $206K | 19,631 |
| 2025-08-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −4,504 | $12.82 | $58K | 16,775 |
| 2025-07-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −4,503 | $11.63 | $52K | 21,279 |
| 2025-06-30 | LEVIN ARTHUR A Director | Option exercise | +1,210 | 2,420 | ||
| 2025-06-30 | LEVIN ARTHUR A Director | Option exercise · Restricted Stock Units | −1,210 | 2,422 | ||
| 2025-06-04 | Skorpios Trust 10% owner | Sale | −3,000,000 | $10.20 | $30.6M | 3,906,181 |
| 2025-06-03 | Smith Julie Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2025-06-03 | LEVIN ARTHUR A Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2025-06-03 | Menzel Garry E Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2025-06-03 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2025-06-03 | Harrison Seth Loring Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2025-06-03 | Burstein Jennifer Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2025-06-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,471 | $10.03 | $65K | 25,782 |
| 2025-06-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,745 | $10.00 | $17K | 32,253 |
| 2025-05-02 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −22,790 | $10.03 | $229K | 33,998 |
| 2025-05-01 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −3,841 | $10.00 | $38K | 56,788 |
| 2025-03-31 | LEVIN ARTHUR A Director | Option exercise | +1,210 | 1,210 | ||
| 2025-03-31 | LEVIN ARTHUR A Director | Option exercise · Restricted Stock Units | −1,210 | 3,632 | ||
| 2025-03-20 | SMITH IAN F Interim CEO | Grant or award · Stock Option (Right to Buy) | +238,420 | 238,420 |
Page 11 of 13 · 256 trades